论文部分内容阅读
小儿特发性血小板减少性紫癜(ITP)是小儿常见的出血性疾病,占小儿出血性疾病总数的25%～40%[1]。由于患儿循环血液中产生抗血小板(Plt)膜抗体,导致Plt免疫性破坏增多而引起Plt减少。传统的治疗方法包括糖皮质激素及大剂量静脉丙种
Pediatric idiopathic thrombocytopenic purpura (ITP) is a common hemorrhagic disease in children, accounting for 25% to 40% of the total number of pediatric hemorrhagic disease [1]. Due to the production of circulating blood in children with anti-platelet (Plt) membrane antibodies, resulting in an increase in Plt immune damage caused by decreased Plt. Traditional treatments include glucocorticoids and high-dose intravenous propranolol